Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors
Source abstract
Abstract
Nanoparticle-mediated siRNA delivery is a promising therapeutic approach, however, the processes required for transport of these materials across the numerous extracellular and intracellular barriers are poorly understood. Efficient delivery of siRNA-containing nanoparticles would ultimately benefit from an improved understanding of how parameters associated with these barriers relate to the physicochemical properties of the nanoparticle vectors. We report the synthesis of three Pluronic(®)-based, cholesterol end-capped cationic polyrotaxanes (PR(+)) threaded with 2-hydroxypropyl-β-cyclodextrin (HPβCD) for siRNA delivery. The biological data showed that PR(+):siRNA complexes were well tolerated (∼90% cell viability) and produced efficient silencing (>80%) in HeLa-GFP and NIH 3T3-GFP cell lines. We further used a multi-parametric approach to identify relationships between the PR(+) structure, PR(+):siRNA complex physical properties, and biological activity. Small angle X-ray scattering and cryoelectron microscopy studies reveal periodicity and lamellar architectures for PR(+):siRNA complexes, whereas the biological assays, ζ potential measurements, and imaging studies suggest that silencing efficiency is influenced by the effective charge ratio (ρeff), polypropylene oxide (PO) block length, and central PO block coverage (i.e., rigidity) of the PR(+) core. We infer from our findings that more compact PR(+):siRNA nanostructures arising from lower molecular weight, rigid rod-like PR(+) polymer cores produce improved silencing efficiency relative to higher molecular weight, more flexible PR(+) vectors of similar effective charge. This study demonstrates that PR(+):siRNA complex formulations can be produced having higher performance than Lipofectamine(®) 2000, while maintaining good cell viability and siRNA sequence protection in cell culture.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. A review of the current status of sirna nanomedicines in the treatment of cancer10.1016/j.biomaterials.2013.04.060 ↗
2. Delivery materials for sirna therapeutics10.1038/nmat3765 ↗
3. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery10.1073/pnas.0703882104 ↗
4. Lipid nanoparticle delivery systems for sirna-based therapeutics10.1007/s13346-013-0161-z ↗
5. Cyclodextrin-based sirna delivery nanocarriers: a state-of-the-art review10.1517/17425247.2011.610790 ↗
6. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic sirna delivery10.1016/j.jconrel.2009.11.008 ↗
7. Effective gene silencing by multilayered sirna-coated gold nanoparticles10.1002/smll.201001314 ↗
8. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering rna delivery10.1002/anie.201101554 ↗
9. Nanoparticle-mediated systemic delivery of sirna for treatment of cancers and viral infections10.7150/thno.9404 ↗
10. Action and reaction: the biological response to sirna and its delivery vehicles10.1038/mt.2011.294 ↗
11. Toxicity profiling of several common rnai-based nanomedicines: a comparative study10.1007/s13346-013-0158-7 ↗
12. Therapeutic face of rnai: in vivo challenges10.1517/14712598.2015.983070 ↗
13. Structure-based design of dendritic peptide bolaamphiphiles for sirna delivery10.1021/acscentsci.5b00233 ↗
14. Supramolecular assemblies in functional sirna delivery: where do we stand?10.1016/j.biomaterials.2011.11.079 ↗
15. Synthesis and characterization of polyrotaxanes consisting of cationic alpha-cyclodextrins threaded on poly[(ethylene oxide)-ran-(propylene oxide)] as gene carriers10.1021/bm700472t ↗
16. Biocleavable polyrotaxane – plasmid DNA polyplex for enhanced gene delivery10.1021/ja055868+ ↗
17. Post-nuclear gene delivery events for transgene expression by biocleavable polyrotaxanes10.1016/j.biomaterials.2012.01.049 ↗
18. Supramolecular control of polyplex dissociation and cell transfection: efficacy of amino groups and threading cyclodextrins in biocleavable polyrotaxanes10.1016/j.jconrel.2008.07.011 ↗
19. Receptor-mediated, tumor-targeted gene delivery using folate-terminated polyrotaxanes10.1021/mp200315c ↗
20. Cellular delivery of polynucleotides by cationic cyclodextrin polyrotaxanes10.1016/j.jconrel.2012.06.040 ↗
21. Cationic alpha-cyclodextrin:Poly(ethylene glycol) polyrotaxanes for sirna delivery10.1021/mp300449t ↗
22. Multi-armed cationic cyclodextrin: poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors10.1039/c2ib20107k ↗
23. Cellular internalization and gene silencing of sirna polyplexes by cytocleavable cationic polyrotaxanes with tailored rigid backbones10.1016/j.biomaterials.2012.12.006 ↗
24. Cationic polyrotaxanes effectively inhibit uptake via carnitine/organic cationic transporters without cytotoxicity10.1002/mabi.200700297 ↗
25. Tailoring the supramolecular structure of aminated polyrotaxanes toward enhanced cellular internalization10.1002/mabi.201300198 ↗
26. 2-hydroxypropyl-beta-cyclodextrin (hp-beta-cd): A toxicology review10.1016/j.fct.2005.03.007 ↗
27. Efficient pdna delivery using cationic 2-hydroxypropyl-beta-cyclodextrin pluronic-based polyrotaxanes10.1002/mabi.201500220 ↗
28. Synthesis of 2-hydroxypropyl-beta-cyclodextrin/pluronic-based polyrotaxanes via heterogeneous reaction as potential niemann-pick type c therapeutics10.1021/bm400922a ↗
29. Cryoelectron microscopic analysis of nucleosomes and chromatin10.1016/S0076-6879(99)04012-4 ↗
30. Cryo-electron microscopy of vitrified specimens10.1017/S0033583500004297 ↗
31. Effects of a delocalizable cation on the headgroup of gemini lipids on the lipoplex-type nanoaggregates directly formed from plasmid DNA10.1021/bm401079h ↗
32. Cationic gemini lipids containing polyoxyethylene spacers as improved transfecting agents of plasmid DNA in cancer cells10.1039/c4tb00389f ↗
33. Existence of hybrid structures in cationic liposome/DNA complexes revealed by their interaction with plasma proteins10.1016/j.colsurfb.2010.08.030 ↗
34. Dendritic cationic lipids with highly charged headgroups for efficient gene delivery10.1021/bc050310c ↗
35. Electrochemical and spectroscopic study of octadecyltrimethylammonium bromide/DNA surfoplexes10.1021/la8034038 ↗
36. Characterization of polyplexes involving small RNA10.1016/j.jcis.2012.07.088 ↗
37. Why is less cationic lipid required to prepare lipoplexes from plasmid DNA than linear DNA in gene therapy?10.1021/ja204693f ↗
38. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? physicochemical and biochemical characterizations and their relevance in gene therapy10.1021/bm301066w ↗
39. Molecular characterization of the interaction between sirna and pamam g7 dendrimers by saxs, itc, and molecular dynamics simulations10.1021/bm101033g ↗
40. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized sirna delivery for gene silencing10.1021/bm401000x ↗
41. A review of nanocarriers for the delivery of small interfering rna10.1016/j.biomaterials.2012.06.068 ↗
42. Progress and perspectives in developing polymeric vectors for in vitro gene delivery10.1039/C2BM00030J ↗
43. Cationic dendron-bearing lipids: investigating structure-activity relationships for small interfering rna delivery10.1021/bm4011563 ↗
44. Self-assembled lamellar complexes of sirna with lipidic aminoglycoside derivatives promote efficient sirna delivery and interference10.1073/pnas.0707431104 ↗
45. Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes10.1016/S0006-3495(99)76942-0 ↗
46. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with sirna10.1021/bi062138l ↗
47. Highly efficient gene silencing activity of sirna embedded in a nanostructured gyroid cubic lipid matrix10.1021/ja1059763 ↗
48. Universality of DNA adsorption behavior on the cationic membranes of nanolipoplexes10.1021/jp9103382 ↗
49. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with sirna10.1021/bi062138l ↗
50. A delocalizable cationic headgroup together with an oligo-oxyethylene spacer in gemini cationic lipids improves their biological activity as vectors of plasmid DNA10.1039/C4TB01948B ↗
51. Mediating high levels of gene transfer without cytotoxicity via hydrolytic cationic ester polymers10.1016/j.biomaterials.2010.01.110 ↗
52. Preparation and characterization of a polyrotaxane consisting of monodisperse poly(ethylene glycol) and.Alpha.-cyclodextrins10.1021/ja00087a004 ↗
53. Restructuring polymers via nanoconfinement and subsequent release10.3762/bjoc.8.151 ↗
54. Alkylimidazolium end-modified poly(ethylene glycol) to form the mono-ion complex with plasmid DNA for in vivo gene delivery10.1021/bm401902j ↗
55. Structural characterization of novel gemini non-viral DNA delivery systems for cutaneous gene therapy10.1080/17458080500411965 ↗
56. High conversion synthesis of pyrene end functionalized polyrotaxane based on poly(ethylene oxide) and alpha-cyclodextrins10.1021/jp054908t ↗